University of the Witwatersrand, Johannesburg, South Africa.
National Institute for Communicable Diseases, Johannesburg, South Africa.
AIDS Res Hum Retroviruses. 2022 May;38(5):350-358. doi: 10.1089/AID.2021.0138. Epub 2021 Nov 25.
The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis, and microbicides in totality-from the molecular details and delivery formulations to the behavioral, social, and structural underpinnings. HIVR4P // Virtual was held over the course of 2 weeks on January 27-28 and February 3-4, 2021 as the coronavirus disease 2019 (COVID-19) pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policymakers, implementers, and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from preclinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights. Complete abstracts, webcasts, and daily rapporteur summaries may be found on the conference website (https://www.hivr4p.org/).
HIV 研究促进预防（HIVR4P）会议促进了关于生物医学 HIV 预防干预措施的知识共享，包括 HIV 疫苗、抗体输注、暴露前预防和杀微生物剂，涵盖了从分子细节和输送配方到行为、社会和结构基础的各个方面。HIVR4P // 虚拟会议于 2021 年 1 月 27 日至 28 日和 2 月 3 日至 4 日举行，为期两周，当时 2019 年冠状病毒病（COVID-19）大流行仍在全球造成前所未有的伤害。HIVR4P 社区聚集了来自 92 个国家的 1802 名研究人员、护理提供者、政策制定者、实施者和倡导者，他们的专业知识涵盖了从临床前到实施的整个 HIV 预防管道。该计划包括 113 次口头报告和 266 次海报展示。本文简要总结了会议的重点。完整的摘要、网络直播和每日报告员摘要可在会议网站（https://www.hivr4p.org/）上找到。
